Organisation Members

All Committee Members of ESO Stroke

Prof. Martin Dichgans

Munich, Germany

President Elect

Martin Dichgans is a Professor of Neurology at Ludwig-Maximilians-Universität, LMU (Munich, Germany). He is the Founding Director of the Institute for Stroke and Dementia Research, Director of the Interdisciplinary Stroke Center Munich, and on the Board of Directors of the DFG funded Excellence cluster ‘Munich Cluster for Systems Neurology (SyNergy)’.

Dr. Bart van der Worp

Dr. Bart van der Worp

Utrecht, Netherlands

Bart van der Worp is a neurologist with a special interest in cerebrovascular diseases at the University Medical Center in Utrecht, the Netherlands. He has been (co-)Chief Investigator of the randomised clinical trials HAMLET, PAIS, COOLIST, and VAST and is (co-)Chief Investigator of PRECIOUS (, APACHE-AF (, and MR ASAP (

Dr. Else Charlotte Sandset

Oslo, Norway
Secretary General

Else Charlotte Sandset graduated as a medical doctor from the Royal College of Surgeons in Ireland in 2006, achieved her PhD from the University of Oslo in Norway in 2012, and completed a year as visiting fellow at the George Institute for Global Health in Sydney, Australia in 2016.

Council of Fellows

Prof. Gary A. Ford

Chair of the Council of Fellows


Gary Ford, FRCP, CBE, FMedSci is Consultant Stroke Physician at the John Radcliffe Hospital, Chief Executive Officer of the Oxford Academic Health Science Network and Visiting Professor of Clinical Pharmacology at Oxford University; he has been a FESO since 2005.

He was Director of the NIHR Stroke Research Network in the UK from 2005-14 and prior member of the Board of Directors of ESO.  He is Chief Executive Officer of the Oxford Academic Health Science Network, a regional health partnership established to spread innovation to improve health and generate economic growth.

He is a consultant stroke physician at the John Radcliffe Hospital in Oxford.  His research interests are pre-hospital diagnosis of stroke, optimal service organisation to deliver hyper acute stroke therapies and effect of age on response to stroke treatments. He developed the FAST and ROISER scales and has published over 250 peer reviewed articles.